
    
      A total of 74 Adult Patients of both genders who had been diagnosed with T2D and are on oral
      anti-hyperglycemic drug and their HbA1C between 7and 8 %, will be enrolled in the study.
      Initially the study protocol will be explained & informed written consent will be obtained
      from all participants. All subjects will be evaluated to ensure that they meet the
      eligibility criteria through: Full history taking, complete physical examination and
      investigations. the intervention group will receive oral magnesium (Mg) supplementation for 3
      months (250 mg of elemental magnesium daily). The primary outcome is to determine the effect
      of Mg supplementation for diabetic patient on serum Mg level, glycemic control and level of
      inflammation.
    
  